Clinical Trial Update: OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for OTX-DED in dry eye disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OTX-DED (dexamethasone)

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Dry Eye Syndromes, Eye Diseases | Phase 2 | Status: COMPLETED